[Levosimendan for postoperative ventricular dysfunction following heart transplantation]

Area of Science:

• Cardiology
• Transplantation Medicine
• Critical Care Medicine

Background:

• Postoperative ventricular dysfunction is a severe complication following heart transplantation.
• It frequently leads to low-output syndrome, increasing early morbidity and mortality.
• Standard hemodynamic therapy with sympathomimetic amines may be insufficient.

Purpose of the Study:

• To evaluate the efficacy and safety of intravenous levosimendan in heart transplant recipients with refractory postoperative ventricular dysfunction.
• To assess levosimendan's impact on hemodynamic status and clinical recovery.

Main Methods:

• Retrospective analysis of 6 heart transplant patients treated with intravenous levosimendan.
• Patients received levosimendan due to inadequate response to sympathomimetic amines.
• Hemodynamic parameters and clinical outcomes were monitored.

Main Results:

• Levosimendan was well tolerated in all patients.
• Significant hemodynamic improvements were observed after levosimendan administration.
• Five out of six patients were successfully weaned from inotropic support and discharged from the ICU.

Conclusions:

• Intravenous levosimendan is a viable and effective treatment option for postoperative ventricular dysfunction after heart transplantation.
• Levosimendan facilitates hemodynamic stabilization and clinical recovery in critical heart transplant patients.
• This inodilator offers a valuable therapeutic strategy when conventional treatments are inadequate.